STAT News

STAT+: Amgen’s Repatha linked to fewer heart attacks

Pithy intro text about the biopharma milieu. Novartis cites more tumor reports after Zolgensma Novartis has disclosed seven previously unreported cases of tumors in children who received Zolgensma, its gene therapy…

By STAT News

1 min read
STAT+: Amgen’s Repatha linked to fewer heart attacks
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights